Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29

Size: px
Start display at page:

Download "Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29"

Transcription

1 April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned To Drive Steady Top- And Bottom-Line Growth; While Generating Strong Cash; Maintain $32 Target E 2019E OLD NEW OLD NEW OLD NEW Mar. $0.20 $0.26 $0.29 $0.30 June Sep Dec EPS $0.90 $1.06 $1.25 $1.33 P/E 21.8x 20.5x Note: NR = Not Rated. Risk Ratings: H = Highly risky; M = Moderately risky E include a respective $0.08, $0.09, $0.07 and $0.07 in stock-based compensation expense. Sum of quarterly EPS may not equal full-year total due to rounding and/or change in share count. NC=Not covered by Sidoti & Co., LLC. Year E 2019E Rev.(Mil.) $28.0 $30.8 $33.2 $33.6 $39.8 $49.9 $50.9 $54.7 $56.7 $59.3 * GAAP EPS* $0.28 $0.45 $0.51 $0.51 $0.69 $0.88 $0.90 $1.06 $1.25 $1.33 * Revenue is net of redistribution fees. Description: OTC Markets Group, Inc. ( operates three lines of business centered on 10,000 U.S. and global securities clients. The company offers a cost-effective solution to penetrate the U.S. securities market, while providing a host of services that connect brokers and dealers, organize markets, and ultimately monetize OTC s vast database of information. OTC s three lines of business are Link ATS (24% of revenue), Market Data (41%) and Corporate Services (35%). Headquarters are in New York, NY. Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29 We forecast 1Q:18 EPS of $0.29, up 10% compared with $0.26 in 1Q:17. We estimate a 4% increase in revenue and lower tax rate offset higher operating costs. We estimate revenue gains of 6% in Corporate Services and 5% in Market Data, somewhat offset by a 4% decline in OTC Link trading-related revenue, with growth attributable to stronger market trends and new service offerings. In our view, OTCM is well positioned to deliver steady revenue and EPS growth, through a more efficient offering in the financial markets, coupled with positive backdrops on both the economic and regulatory fronts. We forecast EPS gains of 18% in 2018 and 6% in 2019, driven by new services, a likely strong IPO market, an increase in the number of companies using OTCM offerings and modest operating leverage. OTCM exited 4Q:17 with cash of $24 million ($2.05 per share) and no debt. We model FCF per share of $1.57 in 2018 and $1.59 in We note that in 2017 OTCM returned $15.4 million to shareholders in the form of dividends and share repurchase. Our $32 price target is based on 24x our 2019 EPS forecast of $1.33. NR Price Target: $32 Price: $27.25 Risk Rating: H Christopher McGinnis (212) (cmcginnis@sidoti.com) Key Statistics Analysts Covering 2 Market Cap (Mil) $310 Enterprise Value $ Week Range (US OTC) Year EPS CAGR 12% Avg. Daily Trading Volume 3,000 Shares Out (Mil) Float Shares (Mil) N/A Insider Ownership 47% Institutional Holdings 53% Annualized Dividend $0.56 Dividend Yield 2.1% FCF Per Share (2019E) $1.59 FCF Yield (2019E) 6% Net Cash Per Share (2019E) $4.16 Price to Book Value 22.6x Return on Equity (2019E) 41.7% Total Debt to Capital Interest Coverage Ratio Short Interest % Short Interest Days To Cover Nil N/A N/A% N/A Russell ,578 Russell 2000 Last 12 Months 12.8% OTCM Last 12 Months 26.7% We model 1Q:18 EPS of $0.29. We estimate revenue of $13.9 million, equating to growth of 4%, compared with $13.4 million in 1Q:17. On a segment basis, we forecast a 6% increase in Corporate Services revenue and 5% growth in Market Data, somewhat offset by a projected 4% decline in OTC Link revenue. We estimate revenue strength reflected a greater number of companies on the OTCQX and OTXQB markets, new product offerings and price increases. In our opinion, the decline in OTC Link trading-related revenue was Required disclosures appear in the Appendix Member FINRA & SIPC 1212 Avenue of the Americas 15 th Floor New York, NY Phone:

2 OTC MARKETS GROUP INC. driven by lower transactional volume and a reduction in the number of broker dealers due to industry consolidation. We forecast an operating margin of 31.1%, down 60 basis points compared with 1Q:17, as we estimate higher compensation and technology costs. We model net income of $3.327 million, up 10% compared with $3.022 million in 1Q:17, leading to EPS of $0.29, also up 10% year over year, aided by a lower tax rate. Exhibit 1: O TC M 1Q :18 Preview $ in th ousands except per sh are data 1Q :17A 1Q :18A YoY Change Revenue $13,376 $13, % Operating Income $4,238 $4, % Operating M argin 31.7% 31.1% Net Income $3,022 $3, % Profit M argin 22.6% 24.0% EPS $0.26 $ % Sources: Company reports and. estimates. OTCM is well positioned for solid growth through 2019, by our forecast. OTCM offers a more efficient option in the financial markets, with services that revolve around greater transparency, more organized markets and improved information at a cost effective subscription-based model. Expanded services and markets led to a 9% revenue CAGR in the last six years and an EPS CAGR of 16%. On the regulatory front, the OTCQX and OTCQB markets are now recognized for Blue Sky exemption status in 29 states. The exemption status will likely drive more smaller companies to use OTCM s services, which offer a simplified and cost efficient pathway to market. Lastly, Regulation A+ simplifies the process of seeking capital for companies looking to raise less than $50 million of proceeds through crowdfunding. While early in the adoption of this new path to market for smaller companies, there were several successful transactions; we expect the rate of adoption of Regulation A+ to increase over time. While we think Regulation A+ is still three to five years away from being a major revenue growth opportunity for OTCM, we see positive data points about adoption of this funding pathway. Given all this, we estimate revenue growth of about 4% in 2018 and 5% in 2019 and EPS growth of 18% in 2018 and 6% in 2019, driven by a lower tax rate and operating leverage. OTCM has a strong balance sheet and a shareholder friendly capital allocation plan, in our view. OTCM exited 4Q:17 with no debt and cash of $24 million ($2.05 per share). OTCM generated free cash flow per share of $1.32 in 2017; we model $1.57 in 2018 and $1.59 in 2019, leading to cash of $48 million ($4.16 per share) at the end of The company s capital spending is relatively modest at less than $1 million annually. Cash flow historically was returned to shareholders in the form of a quarterly dividend, special dividends and share repurchases. In 2017, the company returned a total of $15.4 million to shareholders, up from $14.8 million in The company repurchased 99,302 shares for an average price of $21.91 per share, while also spending $13.3 million in the form of the quarterly dividend of $0.14 per share and the third consecutive special dividend of $0.60 per share. We note that while it is likely there will be more special dividends, we model only quarterly dividends into our forecast. We maintain our $32 target on OTCM shares. This target is based on 24x our 2019 EPS forecast of $1.33. OTCM shares trade at about 22x and 21x our respective 2018 and 2019 EPS forecasts. In the past three years, OTCM shares ranged from 16x-28x forward EPS and averaged 21x. Peers in the corporate service-based industry trade at 18x-26x (average 21x) the consensus 2018 EPS forecast. Although OTCM s lack of liquidity validates the discount to the peers, we view the recurringrevenue model, profit profile, significant operating leverage, capital allocation and dividend payments as offsets. Meanwhile, as crowdfunding is relatively nascent in the capital markets world, we expect that as it matures, the door will open for additional companies to use OTC s services. Key Risks Trading liquidity 2

3 Table 1. OTC Markets Group Inc., Income Statement ($ in thousands, except where noted) OTC MARKETS GROUP INC Mar June Sep Dec 2017 Mar June Sep Dec 2018E Mar June Sep Dec 2019E OTC Link $10,573 $2,618 $2,497 $2,413 $2,546 $10,074 $2,513 $2,397 $2,316 $2,444 $9,671 $2,463 $2,349 $2,270 $2,395 $9,478 Market Data 21,054 5,450 5,522 5,505 5,445 21,922 5,723 5,798 5,780 5,717 23,018 6,066 6,146 6,127 6,060 24,399 Corporate Services 19,254 5,308 5,750 5,704 5,898 22,660 5,626 6,095 6,046 6,252 24,020 5,964 6,461 6,409 6,627 25,461 Total Revenue $50,881 $13,376 $13,769 $13,622 $13,889 $54,656 $13,862 $14,290 $14,143 $14,413 $56,709 $14,493 $14,956 $14,806 $15,083 $59,338 Redistribution fees 2, , , ,773 Net Revenue $48,564 $12,752 $13,143 $13,038 $13,243 $52,176 $13,197 $13,604 $13,478 $13,779 $54,059 $13,797 $14,238 $14,110 $14,419 $56,565 Compensation 19,589 5,566 5,243 5,250 5,421 21,480 5,684 5,473 5,459 5,592 22,208 5,942 5,698 5,700 5,777 23,117 IT Infrastructure 5,469 1,404 1,426 1,499 1,565 5,894 1,525 1,572 1,556 1,585 6,238 1,594 1,645 1,629 1,659 6,527 Professional fees 1, , , ,587 Marketing & Advertising ,010 Occupancy costs 1, , , ,780 D&A 1, , , ,780 General and administrative Total Operating Costs $31,637 $8,514 $8,319 $8,448 $8,592 $33,873 $8,886 $8,731 $8,655 $9,052 $35,324 $9,290 $9,048 $9,002 $9,351 $36,692 Operating Income $16,927 $4,238 $4,824 $4,590 $4,651 $18,303 $4,311 $4,873 $4,823 $4,728 $18,734 $4,507 $5,190 $5,108 $5,068 $19,873 Other incom (costs) Pretax Income $16,935 $4,252 $4,846 $4,595 $4,657 $18,350 $4,321 $4,883 $4,833 $4,738 $18,774 $4,517 $5,200 $5,118 $5,078 $19,913 Income Taxes (6,407) (1,230) (1,800) (1,200) (1,742) (6,100) (994) (1,123) (1,112) (1,090) (4,318) (1,039) (1,196) (1,177) (1,168) (4,580) Net Income $10,528 $3,022 $3,046 $3,395 $2,915 $12,250 $3,327 $3,760 $3,721 $3,648 $14,456 $3,478 $4,004 $3,941 $3,910 $15,333 Less restricted stock ($205) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Net Income To Common $10,323 $3,022 $3,046 $3,395 $2,915 $12,250 $3,327 $3,760 $3,721 $3,648 $14,456 $3,478 $4,004 $3,941 $3,910 $15,333 FD EPS $0.90 $0.26 $0.26 $0.29 $0.25 $1.06 $0.29 $0.33 $0.32 $0.32 $1.25 $0.30 $0.35 $0.34 $0.34 $1.33 FD Shares Outstanding 11,340 11,520 11,520 11,594 11,615 11,562 11,550 11,550 11,550 11,550 11,550 11,550 11,550 11,550 11,550 11,550 Dividend $0.56 $0.14 $0.14 $0.14 $0.14 $0.56 $0.14 $0.14 $0.14 $0.14 $0.56 $0.14 $0.14 $0.14 $0.14 $0.56 EBITDA $20,176 $5,198 $5,861 $5,342 $5,372 $21,773 $5,156 $5,718 $5,668 $5,573 $22,114 $5,364 $6,047 $5,965 $5,925 $23,301 Growth Analysis Revenue YOY Growth 1.9% 4.9% 8.9% 8.0% 7.9% 7.4% 3.6% 3.8% 3.8% 3.8% 3.8% 4.5% 4.7% 4.7% 4.6% 4.6% Adjusted Net Income YoY Growth 2.9% 34.2% 24.2% 16.0% 8.2% 18.7% 10.1% 23.4% 9.6% 25.1% 18.0% 4.5% 6.5% 5.9% 7.2% 6.1% Adjusted FD EPS YoY Growth 2.4% 33.3% 23.3% 14.3% 7.3% 17.7% 9.8% 23.1% 10.0% 25.8% 18.1% 4.5% 6.5% 5.9% 7.2% 6.1% Margin Analysis Operating Margin 34.9% 33.2% 36.7% 35.2% 35.1% 35.1% 32.7% 35.8% 35.8% 34.3% 34.7% 32.7% 36.4% 36.2% 35.1% 35.1% EBITDA Margin 41.5% 40.8% 44.6% 41.0% 40.6% 41.7% 39.1% 42.0% 42.1% 40.4% 40.9% 38.9% 42.5% 42.3% 41.1% 41.2% Adjusted Profit Margin 20.7% 22.6% 22.1% 24.9% 21.0% 22.4% 24.0% 26.3% 26.3% 25.3% 25.5% 24.0% 26.8% 26.6% 25.9% 25.8% Tax Rate 37.8% 28.9% 37.1% 26.1% 37.4% 33.2% 23.0% 23.0% 23.0% 23.0% 23.0% 23.0% 23.0% 23.0% 23.0% 23.0% Sources: Company reports, estimates 3

4 Table 2. OTC Markets Group Inc., Statement of Cash Flows ($ in thousands except where noted) OTC MARKETS GROUP INC Mar June Sep Dec 2017 Sep Dec Mar June 2018E Sep Dec Mar June 2019E Operating Activities Net Income $10,528 $3,022 $3,134 $3,488 $2,915 $12,559 $3,327 $3,760 $3,721 $3,648 $14,456 $3,478 $4,004 $3,941 $3,910 $15,333 Depreciation & amortization 1, , , ,612 Provision for bad debts Share based compensation 1, , , ,816 Excess tax benefit (602) 0 (592) 0 (497) (1,089) Deferred rent (42) 0 76 (29) (69) (22) Deferred income taxes (229) 0 (217) (108) Change in Operating Assets & Liabilities $12,917 $3,786 $3,443 $4,120 $3,508 $14,857 $4,172 $4,605 $4,566 $4,493 $17,836 $4,335 $4,861 $4,798 $4,767 $18,761 Net Change in Working Capital 2,823 2,128 (6,167) 286 5,379 1, (57) (57) 450 1,236 (69) (73) (73) Net Cash Provided by Operations $15,740 $5,914 ($2,724) $4,406 $8,887 $16,483 $5,074 $4,548 $4,509 $4,943 $19,073 $4,266 $4,788 $4,725 $5,559 $19,337 Investing Activities Capital expenditures (415) (150) (238) (280) (497) (1,165) (150) (238) (280) (300) (968) (150) (238) (280) (300) (968) Net Cash Provided by Investing Activities ($415) ($150) ($238) ($280) ($497) ($1,165) ($150) ($238) ($280) ($300) ($968) ($150) ($238) ($280) ($300) ($968) Financing Activities Dividends (13,059) (1,578) (1,620) (1,598) (8,466) (13,262) (1,598) (1,598) (1,598) (1,598) (6,392) (1,598) (1,598) (1,598) (1,598) (6,392) Proceeds from stock options (351) (37) Restricted stock Withholding taxes paid (198) (847) (847) Excess tax benefits Purchase of treasury stock (1,714) 0 (1,692) (483) (1) (2,176) Net Cash Provided by Financing ($14,216) ($1,578) ($3,663) ($2,118) ($8,828) ($16,187) ($1,598) ($1,598) ($1,598) ($1,598) ($6,392) ($1,598) ($1,598) ($1,598) ($1,598) ($6,392) Net Cash Increase (decrease) in cash $1,109 $4,186 ($6,625) $2,008 ($438) ($869) $3,326 $2,712 $2,631 $3,045 $11,713 $2,518 $2,952 $2,847 $3,661 $11,977 Beginning cash balance 24,135 25,244 29,430 22,805 24,813 25,244 24,375 27,701 30,412 33,043 24,375 36,088 38,606 41,557 44,404 36,088 Ending Cash Balance $25,244 $29,430 $22,805 $24,813 $24,375 $24,375 $27,701 $30,412 $33,043 $36,088 $36,088 $38,606 $41,557 $44,404 $48,065 $48,065 CFFO $15,740 $5,914 ($2,724) $4,406 $8,887 $16,483 $5,074 $4,548 $4,509 $4,943 $19,073 $4,266 $4,788 $4,725 $5,559 $19,337 CapEx (415) (150) (238) (280) (497) (1,165) (150) (238) (280) (300) (968) (150) (238) (280) (300) (968) Free Cash Flow $15,325 $5,764 ($2,962) $4,126 $8,390 $15,318 $4,924 $4,310 $4,229 $4,643 $18,105 $4,116 $4,550 $4,445 $5,259 $18,369 FCF / Share $1.35 $0.50 ($0.26) $0.36 $0.72 $1.32 $0.43 $0.37 $0.37 $0.40 $1.57 $0.36 $0.39 $0.38 $0.46 $1.59 Sources: Company reports, estimates 4

5 Table 3. OTC Markets Group Inc., Balance Sheet ($ in thousands except where noted) OTC MARKETS GROUP INC Mar June Sep 2017 Mar June Sep 2018E Mar June S ep 2019E ASSETS Current Assets Cash $25,034 $29,430 $22,805 $24,813 $23,683 $27,701 $30,412 $33,043 $36,088 $38,606 $41,557 $44,404 $48,065 Receivables 6,262 5,460 5,196 5,647 6,450 5,845 5,900 5,956 6,011 6,078 6,149 6,219 5,934 Prepaid income taxes ,331 1,554 1,013 1,013 1,013 1,013 1,013 1,013 1,013 1,013 1,013 Prepaid expenses 1, , , Deferred tax asset Total Current Assets $33,085 $36,154 $31,040 $32,309 $32,449 $35,331 $38,105 $40,798 $43,906 $46,499 $49,531 $52,457 $55,842 PP&E 2,279 2,075 1,876 1,967 2,018 1,777 1,624 1,513 1,422 1,422 1,422 1,422 1,422 Non-current deferred tax asset ,103 1, Goodwill Intangible assets Security deposits Total Assets $36,643 $39,508 $34,598 $36,058 $36,317 $38,958 $41,579 $44,161 $47,178 $49,771 $52,803 $55,729 $59,114 Liabilities Accounts payable Income tax payable Accrued expenses 4,761 4,761 2,950 4,165 4,858 4,858 4,858 4,858 4,858 4,858 4,858 4,858 4,858 Deferred revenue 14,664 14,664 12,263 10,116 15,531 15,531 15,531 15,531 15,531 15,531 15,531 15,531 15,531 Current Liabilities $20,036 $20,043 $15,633 $15,255 $21,175 $20,940 $20,946 $20,951 $20,956 $20,962 $20,969 $20,976 $20,982 Deferred rent Income tax reserve ,024 1,069 1,105 1,105 1,105 1,105 1,105 1,105 1,105 1,105 1,105 Total Liabilities $21,137 $21,202 $16,960 $16,598 $22,526 $22,291 $22,297 $22,302 $22,307 $22,313 $22,320 $22,327 $22,333 Shareholders' Equity Class A Class C Additional paid-in cap 12,988 13,198 13,853 14,267 14,150 14,150 14,150 14,150 14,150 14,150 14,150 14,150 14,150 Retained earnings 6,385 8,975 9,343 11,233 5,682 8,557 11,173 13,750 16,762 19,349 22,374 25,294 28,672 Treasury shares (3,984) (3,984) (5,676) (6,159) (6,160) (6,160) (6,160) (6,160) (6,160) (6,160) (6,160) (6,160) (6,160) Total Stockholders' Equity $15,506 $18,306 $17,638 $19,460 $13,791 $16,666 $19,282 $21,859 $24,871 $27,458 $30,483 $33,403 $36,781 Total Liabilities & Stockholders' Equity $36,643 $39,508 $34,598 $36,058 $36,317 $38,958 $41,579 $44,161 $47,178 $49,771 $52,803 $55,729 $59,114 Key Metrics ROA 28.7% 7.9% 8.2% 9.6% 33.7% 8.8% 9.3% 8.7% 30.6% 7.2% 7.8% 7.3% 25.9% ROE 67.9% 17.9% 16.9% 18.3% 88.8% 21.8% 20.9% 18.1% 58.1% 13.3% 13.8% 12.3% 41.7% ROIC 65.4% 18.6% 16.5% 16.8% 80.1% 21.3% 17.8% 16.2% 59.9% 15.1% 12.8% 11.9% 44.9% Cash per share $2.21 $2.55 $1.98 $2.14 $2.05 $2.40 $2.63 $2.86 $3.12 $3.34 $3.60 $3.84 $4.16 Sources: Company reports, estimates 5

6 Appendix Required Disclosures Required Disclosures OTC Markets Group Inc. (OTCM-$27.25) NR Price Target: $32 Risk Rating: H Rating and Price Target History Table Action Date Px Rating PT Risk Rating Initiation 9/1/16 17 NR 21 H PT 12/23/ PT 8/10/ PT 9/29/ PT 3/7/ Key Risks Trading liquidity Valuation: We maintain our $32 target on OTCM shares. This target is based on 24x our 2019 EPS forecast of $1.33. OTCM shares trade at about 22x and 21x our respective 2018 and 2019 EPS forecasts. In the past three years, OTCM shares ranged from 16x-28x forward EPS and averaged 21x. Peers in the corporate service-based industry trade at 18x-26x (average 21x) the consensus 2018 EPS forecast. Although OTCM s lack of liquidity validates the discount to the peers, we view the recurringrevenue model, profit profile, significant operating leverage, capital allocation and dividend payments as offsets. Meanwhile, as crowdfunding is relatively nascent in the capital markets world, we expect that as it matures, the door will open for additional companies to use OTC s services. Sidoti & Company. is a licensed broker/dealer, and publishes research reports about some of the securities it follows. All research published by is based on public information, or on information from the company discussed in the report that that company is required to promptly make public. This report was prepared for market professionals and institutional investor customers. Market professionals and institutional investors should consider this report as only one factor in making their investment decisions. This report is for information purposes only and is not intended as an offer to sell or a solicitation to buy securities. This research report is not a substitute for the exercise of your independent judgment. Information contained herein is based on sources we believe to be reliable but we do not guarantee their accuracy. The stock rating on this report reflects the analyst s recommendation based on a 12-month period. It should be presumed that the analyst who authored this report has had discussions with the subject company to ensure factual accuracy prior to publication. Sidoti does NOT own securities of the issuers described herein, and Sidoti does not make a market in any securities. Sidoti does not engage in, or receive compensation from, any investment banking or corporate finance-related activities with the company discussed in the report. Sidoti s contracts with issuers protect Sidoti s full editorial control of all research, timing of release of reports, and release from liability for negative reports. To ensure further independence, the company discussed in the report has agreed to a minimum coverage term of one Initiation Report and three Update Reports, which that company cannot unilaterally terminate earlier. takes steps to ensure analyst independence including setting fees in advance and utilizing analysts who must abide by the CFA Institute Code of Ethics and Standards of Professional Conduct. Each Sidoti & Company, LLC analyst has full discretion on the rating and revenue target based on his or her own due diligence. Analysts are paid in part based on overall profitability of. Such profitability is derived from a variety of sources and includes payments received from issuers of securities covered by for services described below. No part of analyst compensation was, or will be, directly or indirectly, related to the specific recommendations or views expressed in any report or article. All issuers to be considered for research obtain the approval of a stock selection committee comprised of the Director of Research, the Chief Compliance Officer, and an independent outside person for screening applicants. Sidoti Company Sponsored Research Rating System The Company Sponsored Research rating 6

7 APPENDIX CONTINUED system consists of Moderately Risky (M) and Highly Risky (H) ratings. Moderately Risky suggests companies, that while still subject to relatively high price volatility, are characterized by more stable and predictable cash flow, a more established operating history, and an operating environment that is somewhat less competitive with a potential for loss of principal. Highly Risky suggests high risk equities of companies with a short or unprofitable operating history, limited or less predictable revenues, very high risk associated with success, significant financial or legal issues, or a substantial risk/loss of principal. As of 04/19/18, Company Sponsored Research Cap Research provides research on 13 companies, of which 8 (61%) are rated Moderately Risky and 5 (38%) are rated Highly Risky. Earnings targets and opinions concerning the composition of market sectors included in this report reflect analyst judgments as of this date and are subject to change without notice. A risk to our earnings targets is that the analyst s estimates or forecasts may not be met. This report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that may cause such differences include, but are not limited to, those discussed in the Risk Factors section in the issuer s SEC filings available in electronic format through SEC Edgar filings at Every company in the Microcap sector bears certain inherent risks and will not provide any company subject to those risks with a rating below moderate because stock in the Microcap segment of the market have many risks that are not as prevalent in Large-Cap, Blue Chips, or even Small-Cap stocks. Often it is these risks that cause Microcap stocks to trade at discounts to their peers. The most common of these risks is liquidity risk, which is typically caused by small trading floats and very low trading volume which can lead to large spreads and high volatility in stock price. In addition, Microcaps tend to have significant company specific risks that contribute to lower valuations. Investors need to be aware of the higher probability of financial default and higher degree of financial distress inherent in the Microcap segment of the market. Sidoti & Company policy is to update research reports as and when the Research Analyst and Research Management deem appropriate, based on developments with the issuer, the sector, or the market that may have a material impact on the research views or opinions stated therein. In addition, certain Research publications are intended to be updated on a regular periodic basis (weekly/monthly/quarterly/annual) and will ordinarily be updated with that frequency, unless the Research Analyst and Research Management determine that a different publication schedule is appropriate based on current conditions. Sidoti & Company Research does not provide individually tailored investment advice. Sidoti & Company Research has been prepared without regard to the circumstances and objectives of those who receive it. Sidoti & Company recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. The appropriateness of an investment or strategy will depend on an investor's circumstances and objectives. The securities, instruments, or strategies discussed in Sidoti & Company Research may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them. Sidoti & Company Research is not an offer to buy or sell or the solicitation of an offer to buy or sell any security/instrument or to participate in any particular trading strategy. The value of and income from your investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, securities/instruments prices, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. If provided, and unless otherwise stated, the closing price on the cover page is that of the primary exchange for the subject company's securities/instruments. These opinions may not fit to your financial status, risk and return preferences. For this reason, to make an investment decision by relying solely to this information stated here may not bring about outcomes that fit your expectations. The trademarks and service marks contained in Sidoti & Company Research are the property of their respective owners. Third-party data providers make no warranties or representations relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages relating to such data. Investors should consider Sidoti & Company Research as only a single factor in making their investment decision. For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada Alternatively you may contact your investment representative or Sidoti & Company Research at 1212 Avenue of the Americas, (Attention: Director of Research), New York, NY USA. Compensation. received a flat fee of $40,000, renewable annually from the company discussed in this report for the creation and dissemination of an Initiation Report and three Update Reports, including this report. The purpose of the fee is to subsidize the high costs of research and monitoring. Sidoti holds a conference twice a year and charges a fee of $5,000 per conference for presenting companies. Sidoti does not currently have a current investment banking services relationship with the company discussed in this report, or contemporaneously with any other companies discussed in other (Sidoti) Company Sponsored Research reports. Sidoti has not received investment banking income from the company discussed in the report in the past 12 months, and does not expect to receive investment banking income from the company discussed in the report in the next 12 months. Of securities rated in other Sidoti Company Sponsored Research reports, Sidoti has received investment banking income from 0 companies (0%) in the past 12 months. Investment banking services, as defined under FINRA Rule 2241, include, among other things, acting as an underwriter in, or as a member of the selling group in, a securities underwriting. Sidoti s role in any issuer s investment banking transaction can be viewed in that issuer s filings at 7

8 APPENDIX CONTINUED Sidoti has non-research employees who will seek compensation for brokerage commission revenue in connection with market trading the securities of this company. has received compensation for non-investment banking services on the Small-Cap Universe, and expects to receive additional compensation for non-investment banking services on the Small- Cap Universe, paid by issuers of securities covered by analysts. These non-investment banking services include investor relations services and software, financial database analysis, advertising services, brokerage services, advisory services, investment research, investment management, non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by. This company has paid a fee to to present at the September 2017 Sidoti Fall Conference. Sidoti Analysts. The research analyst certifies that this report accurately reflects his/her personal views about the subject securities and issuers and that none of the research analyst's compensation was, is or will be, directly or indirectly, related to the analyst's specific recommendations or views contained in this research report. Sidoti policy does not allow an analyst or a member of their household (i) to own, trade, or have any beneficial interest in any securities of any company that analyst covers, or (ii) serve as an officer or director of a covered company. Sidoti employees, including research analysts, receive compensation that is based in part upon the overall performance of the firm, including revenues generated by Sidoti s investment banking and brokerage activities, but compensation is not directly related to investment banking or brokerage revenues. Sidoti maintains and enforces written policies and procedures reasonably designed to prevent any controlling persons, officers (or persons performing similar functions), or employees of Sidoti from influencing the activities of research analysts and the content of research reports prepared by the research analyst. Sidoti research analysts seek to have management of their covered companies meet with investors during non-deal road shows. Analysts compensation may be related to their success in scheduling non-deal road shows. This approach could be viewed as presenting potential conflicts of interest. Reprints of reports are prohibited without permission. Additional information is available upon request. For any further questions, please contact the Chief Compliance Officer at Sidoti. Source Key Statistics data is sourced from FactSet Research Systems 8

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC September 29, 2017 Company Sponsored Research Morning Meeting Note Raise Price Target; Raise Earnings Estimates OTC Markets Group Inc. (OTCM) Equity Research Raise Target To $30 (From $27) As We Introduce

More information

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook

More information

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends

More information

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC October 27, 2017 Company Sponsored Research Morning Meeting Note Earnings Release Socket Mobile, Inc. (SCKT) Equity Research Maintain $6 Price Target; Robust Demand From Application Developer, Despite

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02 October 9, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview Sify Technologies Limited Sponsored ADR (SIFY) Equity Research Expect 2Q:F19 EPS Will Be Flat Year Over Year On 15% Higher

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC November 1, 2018 Intraday Note Raise Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research Increase 2019 EPS Estimate After This Morning s Solid 3Q:18 Report; 3Q:18 EPS Of $0.27 Beat Our

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC February 28, 2019 Intraday Note Lower Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research 4Q:18 Revenue Beats, But EPS Misses On Soft Gross Margin; Although Backlog Supports Growth,

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.55) Morning Meeting Note NEUTRAL

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC December 16, 2016 Morning Meeting Note Raise Price Target AAON, Inc. (AAON) Equity Research Raise Target To $34 (From $28) On Anticipation Of A Lower Tax Rate; Continue To Forecast Strong Growth In 2017-2018;

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC December 13, 2018 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research In Our View, AAON s Outlook For 2019 Is Positive Based On Backlog, Order Trend And Price/Cost; However, We Are Cautious

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC September 15, 2017 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research We Maintain Our Outlook For Robust Growth For AAON, Following A Peer s Positive Commentary Earlier This Week; Maintain

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.20) Morning Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$20.47) Intraday Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$27.84) Morning Meeting Note NEUTRAL

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$23.39) Morning Meeting Note NEUTRAL

More information

TD AMERITRADE HOLDING CORPORATION CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts (Unaudited)

TD AMERITRADE HOLDING CORPORATION CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts (Unaudited) CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts Revenues: Transaction-based revenues: Commissions and transaction fees $ 301,272 $ 309,388 $ 265,442 $ 610,660 $ 552,555 Asset-based

More information

Second Quarter 2017 Financial Highlights:

Second Quarter 2017 Financial Highlights: Snap Inc. Reports Second Quarter 2017 Results VENICE, Calif. August 10, 2017 Snap Inc. (NYSE: SNAP) today announced financial results for the quarter ended 2017. Second Quarter 2017 Financial Highlights:

More information

Research Report Update Investors should consider this report as only a single factor in making their investment decision.

Research Report Update Investors should consider this report as only a single factor in making their investment decision. The Standard of Excellence in the Microcap Market Member: NASD, SIPC Research Report Update Investors should consider this report as only a single factor in making their investment decision. AeroCentury

More information

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) June 30, September 30, 2018 2017 ASSETS: Current assets: Cash and cash equivalents $ 119,929 $ 105,618 Accounts receivable, net 182,419 168,586 Prepaid

More information

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) 2018 2017 ASSETS: Current assets: Cash and cash equivalents $ 90,023 $ 105,618 Accounts receivable, net 208,865 168,586 Prepaid expenses and other current

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

ALPHA SELECT LIST CAS Medical Systems, Inc.

ALPHA SELECT LIST CAS Medical Systems, Inc. A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst

More information

Change (Unaudited)

Change (Unaudited) Snap Inc. Reports First Quarter 2018 Results VENICE, Calif. May 1, 2018 Snap Inc. (NYSE: SNAP) today announced financial results for the quarter ended 2018. First Quarter 2018 Financial Highlights: Percent

More information

Research Note Investors should consider this report as only a single factor in making their investment decision.

Research Note Investors should consider this report as only a single factor in making their investment decision. Research Note Investors should consider this report as only a single factor in making their investment decision. John Nobile AIRI $1.38 (NYSE MKT) July 28, 2017 2013A 2014A 2015A 2016A Revenues (millions)

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK Small-Cap Research February 22, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF:

More information

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy 23-Apr-14 14-May-14 4-Jun-14 25-Jun-14 16-Jul-14 6-Aug-14 27-Aug-14 17-Sep-14 8-Oct-14 29-Oct-14 19-Nov-14 10-Dec-14 31-Dec-14 21-Jan-15 11-Feb-15 4-Mar-15 25-Mar-15 15-Apr-15 Daily Volume ('000) Share

More information

SNAP INC. (Exact name of Registrant as Specified in Its Charter)

SNAP INC. (Exact name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Comcast EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Comcast 2Q16 Follow-Up: Raising Price Target to $74, 8x 2017E EBITDA.

Comcast EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Comcast 2Q16 Follow-Up: Raising Price Target to $74, 8x 2017E EBITDA. EQUITY RESEARCH QUARTERLY UPDATE July 29, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $74.00 CMCSA - NASDAQ $67.86 3-5 Yr. EPS Gr. Rate 17% 52-Wk Range $68.36-$50.01 Shares Outstanding 2,446.0M

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive July 5, 2018 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Medical Transcription

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) March 31, September 30, 2016 2015 ASSETS: Current assets: Cash and cash equivalents $ 85,374 $ 86,120 Accounts receivable, net 155,207 158,773 Prepaid

More information

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited)

FAIR ISAAC CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) June 30, September 30, 2016 2015 ASSETS: Current assets: Cash and cash equivalents $ 118,155 $ 86,120 Accounts receivable, net 155,196 158,773 Prepaid

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2016 PhaseRx (PZRX - $ 1.08) Positive Preclinical Large Animal Study Results; An Important Step For Demonstrating

More information

Turkcell EARNINGS REVIEW 4Q17. Digital transformation on track BUY

Turkcell EARNINGS REVIEW 4Q17. Digital transformation on track BUY EARNINGS REVIEW 4Q17 Turkey Telecom Services 16 February 2018 Turkcell Digital transformation on track We maintain our BUY recommendation for Turkcell with a 12M target price of TRY17.54, which offers

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 16, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. (NETE-NASDAQ)

More information

SNAP INC. (Exact name of Registrant as Specified in Its Charter)

SNAP INC. (Exact name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK CPKF: Third Quarter Results Justify CPKF s Recent 7% Dividend Increase

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK CPKF: Third Quarter Results Justify CPKF s Recent 7% Dividend Increase Small-Cap Research November 25, 2015 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 111 North Canal Street Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK

More information

BTO: Q2/15 Earnings Preview

BTO: Q2/15 Earnings Preview B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com

More information

Wells Fargo & Company

Wells Fargo & Company March 04, 2015 Wells Fargo & Company Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation N/A Date of Last Change 04/07/2000 Current Price (03/03/15) $55.45 Target Price $58.00 52-Week High

More information

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90 EARNINGS REVIEW 4Q17 Turkey Aviation 22 February 2018 TAV Airports Bottom-line below consensus We reduce our recommendation to Hold, while keeping our target price unchanged at TRY22.90/shr. We believe

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

CLICK TO EDIT MASTER TITLE STYLE Market Perspective

CLICK TO EDIT MASTER TITLE STYLE Market Perspective Market Perspective Global Earnings Remain Supportive November 8, 2017 Keith Lerner, CFA, CMT Managing Director, Chief Market Strategist 2017 SunTrust Banks, Inc. SunTrust is a federally registered service

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.32) BARDA Decision is a Major Positive Development Yesterday, CYTX

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2018 Viking Therapeutics (VKTX - $13.74) 3Q18: Conference Call Uneventful with Investor Focus on the Design

More information

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK. CPKF: Spectacular Quarter with Diluted EPS Surging 32% Year over Year

Small-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK. CPKF: Spectacular Quarter with Diluted EPS Surging 32% Year over Year Small-Cap Research June 15, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF: Spectacular

More information

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES Small-Cap Research August 17, 2017 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. NETE: Russian Restructuring Should Reduces Losses

More information

Net Element Inc. (NASDAQ: NETE)

Net Element Inc. (NASDAQ: NETE) NEW YORK SÃO PAULO TORONTO Research Note Inc. (NASDAQ: ) reported developments in both its Netevia platform and Unified Payments subsidiary. intends to improve reveneue generation by extending its Netevia

More information

ASV HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter)

ASV HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

News Release H&R Block Announces Fiscal 2014 Results CEO Perspective

News Release H&R Block Announces Fiscal 2014 Results CEO Perspective News Release For Immediate Release: June 11, 2014 H&R Block Announces Fiscal 2014 Results Total revenues increased $118 million, or 4%, to $3.024 billion 1 EBITDA increased 8% to $940 million, or 31% of

More information

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share Small-Cap Research September 15, 2017 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Snap Interactive (STVI-OTC) STVI: LiveXLive Offer Represents More Than

More information

Q Earnings Key Metrics

Q Earnings Key Metrics Q1 2018 Earnings Key Metrics LPL Financial Holdings Inc. Q1 2018 Earnings May 3, 2018 Member FINRA/SIPC 1 Notice to Investors: Safe Harbor Statement Statements in this presentation regarding LPL Financial

More information

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research May 15, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying

More information

Stellent, Inc. (STEL - $8.59)

Stellent, Inc. (STEL - $8.59) Richard A. Ryan raryan@feltl.com (612) 492-8841 Enterprise Software August 7, 2006 Financial Summary Rev(mil) 2005 2006 2007E Jun $22.3 $28.6 $32.3A Sep $28.0 $30.1 $33.4E Dec $27.7 $31.7 $34.8E Mar $28.5

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 23, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc. LEAI:

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 21, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc.

More information

Closed-End Equity Funds

Closed-End Equity Funds RESEARCH WEALTH MANAGEMENT INVESTMENT RESOURCES MAY 25, 2016 Closed-End Equity Funds NORTH AMERICA CHRISTOPHER K. BAXTER Morgan Stanley Wealth Management Christopher.Baxter@morganstanley.com +1 212 296-2562

More information

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK Small-Cap Research August 5, 2015 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and

More information

Company Overview. Industry Overview. Financial Performance

Company Overview. Industry Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 27.80 January 20, 2016 Stock Details BSE code 534623 BSE ID JUPITERIN Face value ( ) 10 No of shares (m) 10 52 week

More information

Small-Cap Research. OxySure Systems, Inc. (OXYS-OTCQB) OXYS: Another Strong Quarter As Company Preps for European Market UPDATE SUMMARY DATA

Small-Cap Research. OxySure Systems, Inc. (OXYS-OTCQB) OXYS: Another Strong Quarter As Company Preps for European Market UPDATE SUMMARY DATA Small-Cap Research May 16, 2014 Jason Napodano, CFA David Bautz, PhD 312-265-9421 / jnapodano@zacks.com scr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago, IL 60606 OxySure Systems, Inc. OXYS: Another

More information

Digital River, Inc. Second Quarter Results (Unaudited, in thousands) Subject to reclassification

Digital River, Inc. Second Quarter Results (Unaudited, in thousands) Subject to reclassification (Unaudited, in thousands) Condensed Consolidated Balance Sheets As of December 31, 2008 2007 Assets: Current assets Cash and cash equivalents $ 276,927 $ 381,788 Short-term investments 201,297 315,636

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.49) Patient Recruitment for Vepoloxamer Pivotal (EPIC) Trial is On-track

More information

[Please refer to Appendix. Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid RAISING PRICE TARGET

[Please refer to Appendix. Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid RAISING PRICE TARGET July 26, 2016 Baird Equity Research Connected Technology Verizon Communications, Inc. (VZ) Competition Weighing on Revenue, but Cash Flow Solid Maintain Neutral rating. This morning, Verizon reported mixed

More information

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade. Quarterly Report CEMEX Market Outperformer 2017 Price Target US$11.0 Price 8.9 12M Price Range 4.1/9.5 Shares Outstanding (Mill)* 1,545 Market Cap USD (Mill) 13,797 Float 78.6% Net Debt USD (Mill)** 12,516

More information

National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results

National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results Duluth, Ga. -- Mar. 8, 2018 -- National Vision Holdings, Inc. (NASDAQ: EYE) ( National Vision or the Company ) today

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in

More information

22nd Century Group, Inc. (XXII - $ Buy) Q3 Better than Expected

22nd Century Group, Inc. (XXII - $ Buy) Q3 Better than Expected Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $1.33 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Analyst, +1-646-465-9034 jmcilree@chardancm.com Sales

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 1, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Revolution Lighting Technologies,

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.56) Rivipansel (GMI-1070) in Resolving Vaso-occlusive Crisis (VOC) of

More information

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary Equity Research Consumer Discretionary Goodbaby (1086 HK) Buy (maintained) Target price: HK$4.20 1H16 results miss, but margin expansion continues Maintain Buy Net profit rose 21% YoY to HK$107m in 1H16,

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.61) 2Q14: EPIC Study On-track and More Details of Other Pipeline Developments

More information

Financial and Operating Results. Second Quarter and First Half 2016

Financial and Operating Results. Second Quarter and First Half 2016 Financial and Operating Results Second Quarter and First Half 2016 August 2016 Safe Harbor Statement Forward Looking Statements In addition to historical information, this earnings presentation contains

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report June 1, 2018 Viking Therapeutics (VKTX - $9.99) Outlook of VK2809 in NAFLD Continues to Improve; Increase Our Target

More information

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115.

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115. OTC Markets Group Record quarterly revenues Q115 results Financial services OTC Markets Group (OTCQX: OTCM) continued to perform well in Q115 with revenue rising as a result of its Corporate services initiative

More information

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE 9 27 31 A S D 10 2016 4 S N D 14 18 2017 26 2 2018 8 16 22 29 F 5 12 20 26 LIVEXLIVE ED IA O RD (5.81000, 5.974,5.67000,5.77000,+0.01000) Relative Strength Index (45.7825) 5 12 19 26 2 A 9 16 23 30 7 14

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced

More information

American Tower Corp. AMT 3Q16 Results: Solid Quarter with a Beat and Raise on EBITDA

American Tower Corp. AMT 3Q16 Results: Solid Quarter with a Beat and Raise on EBITDA EQUITY RESEARCH COMPANY UPDATE October 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $130.00 AMT - NYSE $115.67 3-5 Yr. EPS Gr. Rate 20% 52-Wk Range $118.26-$83.07 Shares Outstanding 430.0M

More information

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Consumer: Automotive Retail AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Maintaining SW: 1) auto retail industry growth outlook remains

More information

All per share amounts are based on fully diluted shares at the end of the corresponding period.

All per share amounts are based on fully diluted shares at the end of the corresponding period. News Release For Immediate Release: June 12, 2018 H&R Block Reports Improved Results for Fiscal 2018 and Dividend Increase; To Provide Outlook for Fiscal 2019 Revenues increased 4 percent to $3.2 billion

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20. Equity Research Information Technology Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 2Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$2.77 2Q16 results in

More information

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED Medifast, Inc. NYSE: MED Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. Medifast engages in the production, distribution, and sale of weight loss and weight loss

More information

Chow Tai Fook (1929 HK)

Chow Tai Fook (1929 HK) Equity Research Consumer Discretionary Hold (maintained) Target price: HK$8.50 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited 29-30/F,

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks SmallCap Research Sponsored Impartial Comprehensive May 11, 2018 Lisa Thompson 3122659154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Chicken Soup For The Soul Entertainment

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive November 15, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. (NETE-NASDAQ)

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.07) Management Updates on Lorem Vascular Partnership and Others This

More information

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY? Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target

More information

Balkrishna Industries

Balkrishna Industries India I Equities Auto Result Update Change in Estimates Target Reco 13 February 2017 Balkrishna Industries All-round performance, margin guidance reduced; Hold Seventy-five percent of the products of Balkrishna,

More information

OTC Markets Crowdfunding Overview. March 2016

OTC Markets Crowdfunding Overview. March 2016 OTC Markets Crowdfunding Overview March 2016 Table of Contents OTC Markets Group Company Overview Key Market Statistics OTCQX & OTCQB JOBS Act & Crowdfunding Overview Title II General Solicitation Title

More information

Mar. 31, Jun. 30, 2017

Mar. 31, Jun. 30, 2017 Consolidated GAAP Statements of Operations ($ in thousands, except EPS) March 31, ended Net Revenues $921,580 $1,059,429 $1,134,224 $191,972 $209,032 $195,443 $593,755 $1,190,202 $199,725 Consumer 870,959

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive March 19, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Aralez Pharmaceuticals

More information

LPL Financial Announces Second Quarter 2018 Results

LPL Financial Announces Second Quarter 2018 Results Investor Relations - Chris Koegel, (617) 897-4574 For Immediate Release Media Relations - Jeff Mochal, (704) 733-3589 investor.lpl.com/contactus.cfm LPL Financial Announces Second Quarter 2018 Results

More information

TD Ameritrade. Citi Asset Management Broker Dealer & Exchanges Investor Conference New York, NY March 3, Fred Tomczyk Chief Executive Officer

TD Ameritrade. Citi Asset Management Broker Dealer & Exchanges Investor Conference New York, NY March 3, Fred Tomczyk Chief Executive Officer TD Ameritrade Citi Asset Management Broker Dealer & Exchanges Investor Conference New York, NY March 3, 2016 Fred Tomczyk Chief Executive Officer TD Ameritrade Holding Corporation (Nasdaq: AMTD). Brokerage

More information

OTC Markets Group Inc. (OTCQX: OTCM)

OTC Markets Group Inc. (OTCQX: OTCM) OTC Markets Group Inc. (OTCQX: OTCM) Bea Ordonez, Chief Financial Officer Daniel Zinn, General Counsel September 2017 EXECUTIVE SUMMARY Mission Create better informed & more efficient financial markets

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.15) Continued Execution, EU Uveitis Potential Approval Imminent We recently spent some

More information

China Renewable Energy Investment Ltd (987_HK)

China Renewable Energy Investment Ltd (987_HK) Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9

More information

Cullen/Frost Bankers, Inc.

Cullen/Frost Bankers, Inc. December 26, 2014 Cullen/Frost Bankers, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 11/30/2001 Current Price (12/25/14) $70.74 Target Price $74.00

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive January 29, 2018 John D. Vandermosten, CFA 312-265-9588 / jvandermosten@zacks.com scr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago,

More information

Iljin Materials ( KS)

Iljin Materials ( KS) (020150 KS) Removal of subsidiary risks brightens outlook Technology Results Comment (Upgrade) Buy Target Price (12M, W) 13,600 Share Price (3/4/16, W) 11,150 Expected Return 22% OP (15, Wbn) -28 Consensus

More information

OTC MARKETS GROUP INC.

OTC MARKETS GROUP INC. OTC MARKETS GROUP INC. A Delaware Corporation 304 Hudson Street New York, NY 10013 Telephone: (212) 896-4400 Facsimile: (212) 868-3848 Federal EIN: 13-3941069 NAICS: 523210 SIC Code: 6289 Issuer s Quarterly

More information